Unlock More Data From Automated Adherent Cell Assays
What We Do
Turn adherent cells into barcoded, assay-ready reagents
SemaCyte® microcarriers are ultra-miniaturised, barcoded micro-wells that carry small colonies of adherent cells in a uniform geometry. Move them with standard liquid handling, control orientation magnetically, and cryopreserve cells as assay-ready batches for on-demand experiments.
Multiplex cell models in the same well to screen faster
Fully compatible with automated 384-well workflows, SemaCytes enable cell multiplexing so multiple engineered, primary, or patient-derived models can be combined in a single well and decoded by optical barcode. This reduces plates, reagents, and imaging time while improving comparability by running models side-by-side.
Who We Are
Microfabricated smart materials for scalable adherent cell assays
Semarion’s mission is to accelerate in vitro drug discovery by removing bottlenecks in adherent cell screening. We help teams generate better data, faster, by making adherent cell assays easier to standardise, automate, and scale.
We are an advanced materials engineering company building SemaCyte® microcarriers using microchip-style microfabrication. This gives precise control over geometry, surfaces, and optical barcodes, enabling adherent cells to become assay-ready reagents that can be moved, pooled, and decoded within standard microplate workflows.
We envision a future where adherent cell biology is as batchable and automation-ready as today’s suspension workflows. By combining barcode-based multiplexing with assay-ready cryopreserved cells, we aim to make high-content screening more comparable across experiments while reducing the time, cost, and variability that slow discovery.
News
Featured
Semarion Win’s SLAS’s New Product Award in San Diego
Our Partners
